Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kriegsmann

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Proteomics. Clinical Applications|February 1, 2020
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's DiseaseKarim Arafah, Mark Kriegsmann, Marcus Renner, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
Genes, Chromosomes & Cancer|May 2, 2015
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosisNicole Pfarr, Mark Kriegsmann, Peter Sinn, et al.
Cold Spring Harbor Molecular Case Studies|October 7, 2022
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case reportChristiane Wiedemann, Daniel Kazdal, Jelena Cvetkovic, et al.
Proteomics. Clinical Applications|September 15, 2018
Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary AdenocarcinomaDaniel Kazdal, Rémi Longuespée, Steffen Dietz, et al.
Acta Neuropathologica Communications|March 4, 2018
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometryRémi Longuespée, Annika K Wefers, Elena De Vita, et al.
Frontiers in Oncology|July 26, 2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung CarcinomaDavid Fisch, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Proteomics. Clinical Applications|March 3, 2022
Robust subtyping of non-small cell lung cancer whole sections through MALDI mass spectrometry imagingCharlotte Janßen, Tobias Boskamp, Lena Hauberg-Lotte, et al.
Cancers|May 16, 2023
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung ResectionTommaso A Dragani, Thomas Muley, Marc A Schneider, et al.
Nature Communications|May 30, 2019
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cellsMarc Rosenbaum, Andreas Gewies, Konstanze Pechloff, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Proteomics. Clinical Applications|February 1, 2020
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's DiseaseKarim Arafah, Mark Kriegsmann, Marcus Renner, et al.
Cancers|December 1, 2020
Epigenetic Inactivation of the Tumor Suppressor <i>IRX1</i> Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired PrognosisMiriam M Küster, Marc A Schneider, Antje M Richter, et al.
Genes, Chromosomes & Cancer|May 2, 2015
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosisNicole Pfarr, Mark Kriegsmann, Peter Sinn, et al.
Cold Spring Harbor Molecular Case Studies|October 7, 2022
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case reportChristiane Wiedemann, Daniel Kazdal, Jelena Cvetkovic, et al.
Proteomics. Clinical Applications|September 15, 2018
Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary AdenocarcinomaDaniel Kazdal, Rémi Longuespée, Steffen Dietz, et al.
Acta Neuropathologica Communications|March 4, 2018
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometryRémi Longuespée, Annika K Wefers, Elena De Vita, et al.
Frontiers in Oncology|July 26, 2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung CarcinomaDavid Fisch, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Proteomics. Clinical Applications|March 3, 2022
Robust subtyping of non-small cell lung cancer whole sections through MALDI mass spectrometry imagingCharlotte Janßen, Tobias Boskamp, Lena Hauberg-Lotte, et al.
Cancers|May 16, 2023
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung ResectionTommaso A Dragani, Thomas Muley, Marc A Schneider, et al.
Nature Communications|May 30, 2019
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cellsMarc Rosenbaum, Andreas Gewies, Konstanze Pechloff, et al.
Pageof 18